BioWorld

July 10, 2003

Front-Running DD3PCA3 Gene Faced Off PSA Test Of Prostate Carcinoma In First-Shot Urology Clinic Line-Up

Correction

Other News To Note

Appointments And Advancements

U.S. Patent Disclosures

PDL Sells $250M In Notes To Pay Down Old Debt, Fund Expansion

Protein Design Labs Inc. is planning to replace old debt with new after gaining $250 million through the sale of convertible subordinated notes in a private placement. (BioWorld Today) Read More

Neurion's CNS Technologies Attracting Pharma Attention

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...